Table 1 Primers to sequence JEV

From: The molecular determinants governing the immunogenicity of Japanese encephalitis live attenuated vaccines

Primers

Sequences

Positions (nt)

P1

P1L:5′- AGAAGTTTATCTGTGTGAACTTCTTGG-3′

1–27

 

P1R:5′- TATCGAAGGAGCATTGGG-3′

1488–1505

P2

P2L:5′- GAGAAGCCCACAACGAGAAG-3′

1210–1229

 

P2R:5′- GAATCGTAGGGGCGGAAG 3′

3428–3446

P3

P3L:5′- GAACTCATCATTCCGCATACCATAG-3′

3195–3220

 

P3R:5′- CCATTTTCGGTCAAACCTCC-3′

4855–4874

P4

P4L:5′- TAGCCGCCCTCACGCCTTG-3′

4534–4552

 

P4R:5′- CAGTGCATCTGGCAGCTCTTCG-3′

6596–6617

P5

P5L:5′- GGAAAATCCTCAAGCCGAGAT-3′

6373–6393

 

P5R:5′- TCAGGAGCCTTCGTGTCAACT-3′

8706–8726

P6

P6L:5′- CAGGTACTACTGGGGCGAATG-3′

8388–8408

 

P6R:5′- TCCTCTGCACGGGACAACTAT-3′

9861–9881

P7

P7L:5′- AAGACCGTGATGGACGTGATATC-3′

9444–9466

 

P7R:5′- AGATCCTGTGTTCTTCCTCACC-3′

10 952–10 977

  1. Abbreviations: JEV, Japanese encephalitis virus; nt, nucleotide.